Condition: Cutaneous Melanoma
rs1636744
in
AHR
gene and
Cutaneous Melanoma
PMID 26237428
2015 Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.
PMID 30429480
2018 Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways.
rs1057519786
in
ARAF
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs72704658
in
ARNT
gene and
Cutaneous Melanoma
PMID 30429480
2018 Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways.
rs1023835002
in
B2M;PATL2
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs113488022
in
BRAF
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs73008229
in
C11orf65;ATM
gene and
Cutaneous Melanoma
PMID 30429480
2018 Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways.
rs1057519918
in
CASC11;MYC
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs35158985
in
CDH1
gene and
Cutaneous Melanoma
PMID 26237428
2015 Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.
rs104894340
in
CDK4
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs6914598
in
CDKAL1
gene and
Cutaneous Melanoma
PMID 26237428
2015 Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.
rs104894104
in
CDKN2A
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs1057519885
in
CFAP61;CRNKL1
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs380286
in
CLPTM1L
gene and
Cutaneous Melanoma
PMID 30429480
2018 Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways.
rs1057519955
in
CNOT9
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs1057519884
in
CREBBP
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs1057519886
in
CTNNB1
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs4670813
in
CYP1B1-AS1;CYP1B1
gene and
Cutaneous Melanoma
PMID 30429480
2018 Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways.
rs267600971
in
CYP21A2;STK19;DXO
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs600951
in
DOCK8
gene and
Cutaneous Melanoma
PMID 30429480
2018 Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways.
rs1057519890
in
ERBB2
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs1057519894
in
EZH2
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs75570604
in
FANCA
gene and
Cutaneous Melanoma
PMID 30429480
2018 Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways.
rs1057519896
in
FBXW7
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs117648907
in
FMN1
gene and
Cutaneous Melanoma
PMID 30429480
2018 Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways.
rs12596638
in
FTO
gene and
Cutaneous Melanoma
PMID 30429480
2018 Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways.
rs1057519742
in
GNA11
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs11554273
in
GNAS
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs4731207
in
GPR37
gene and
Cutaneous Melanoma
PMID 26237428
2015 Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.
rs1640875
in
GPRC5A
gene and
Cutaneous Melanoma
PMID 30429480
2018 Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways.
rs55875066
in
HDAC4
gene and
Cutaneous Melanoma
PMID 30429480
2018 Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways.
rs104894230
in
HRAS;LRRC56
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs121913499
in
IDH1
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs1057519880
in
IRF3;BCL2L12
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs1057519907
in
KIT
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs868438023
in
KNSTRN
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs17851045
in
KRAS
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs4731742
in
LINC-PINT
gene and
Cutaneous Melanoma
PMID 26237428
2015 Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.
rs10739221
in
LINC01505
gene and
Cutaneous Melanoma
PMID 26237428
2015 Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.
PMID 30429480
2018 Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways.
rs2290419
in
LOC338694
gene and
Cutaneous Melanoma
PMID 26237428
2015 Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.
rs104894226
in
LRRC56;HRAS
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs1057519728
in
MAP2K1
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs1057519910
in
MAP2K2
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs1148732
in
MIR614;GPRC5A
gene and
Cutaneous Melanoma
PMID 30429480
2018 Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways.
rs11532907
in
MTAP
gene and
Cutaneous Melanoma
PMID 30429480
2018 Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways.
rs1057519917
in
MTOR
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs416981
in
MX2
gene and
Cutaneous Melanoma
PMID 30429480
2018 Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways.
rs756091827
in
MYC;CASC11
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs34466956
in
NFIC
gene and
Cutaneous Melanoma
PMID 30429480
2018 Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways.
rs11554290
in
NRAS
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs4778138
in
OCA2
gene and
Cutaneous Melanoma
PMID 26237428
2015 Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.
rs1057519879
in
PATL2;B2M
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs56238684
in
PIGU
gene and
Cutaneous Melanoma
PMID 30429480
2018 Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways.
rs104886003
in
PIK3CA
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs1057519757
in
PIK3R1
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs132985
in
PLA2G6
gene and
Cutaneous Melanoma
PMID 30429480
2018 Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways.
rs251464
in
PPARGC1B
gene and
Cutaneous Melanoma
PMID 30429480
2018 Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways.
rs763733111
in
PPP6C
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs121909224
in
PTEN
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs1057519874
in
RAC1
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs80338796
in
RAF1
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs6750047
in
RMDN2
gene and
Cutaneous Melanoma
PMID 26237428
2015 Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.
rs1057519961
in
SF3B1
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs1057519959
in
SF3B2
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs2995264
in
STN1
gene and
Cutaneous Melanoma
PMID 26237428
2015 Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.
rs2357176
in
SYNE2
gene and
Cutaneous Melanoma
PMID 30429480
2018 Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways.
rs45575338
in
TASOR2
gene and
Cutaneous Melanoma
PMID 30429480
2018 Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways.
rs1057519747
in
TP53
gene and
Cutaneous Melanoma
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs184628474
in
TTC7B
gene and
Cutaneous Melanoma
PMID 30429480
2018 Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways.
rs10830253
in
TYR
gene and
Cutaneous Melanoma
PMID 30429480
2018 Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways.
rs186133190
in
WDPCP
gene and
Cutaneous Melanoma
PMID 26237428
2015 Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.